Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The study objective is to:
1. To evaluate the effect of sildenafil citrate versus placebo on the IIEF_EF Domain at the
end of the double-blind phase
2. To assess the relationship between treatment with sildenafil citrate or placebo and
responses to the Quality of Erection Questionnaire (QEQ) and Sexual Experience
Questionnaire (SEX_Q).
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.